Gujarat Terce Laboratories Limited (BOM:524314)

India flag India · Delayed Price · Currency is INR
41.31
-0.15 (-0.36%)
At close: Feb 12, 2026
Market Cap297.32M -52.8%
Revenue (ttm)483.98M -1.5%
Net Income-12.81M
EPS-1.66
Shares Out7.79M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,415
Average Volume5,016
Open41.50
Previous Close41.46
Day's Range41.00 - 42.28
52-Week Range37.20 - 79.85
Beta0.83
RSI40.45
Earnings DateFeb 4, 2026

About BOM:524314

Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, Codimol, Cefter, and Terflora brands. Gujarat Terce Laboratories Limited was incorporate... [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 244
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524314
Full Company Profile

Financial Performance

Financial Statements